87694-55-1

Basic information

• Product Name: TERT-BUTYL [(1S,3S)-1-FORMYL-3-METHYLPENTYL]CARBAMATE
• Synonyms: TERT-BUTYL [(1S,3S)-1-FORMYL-3-METHYLPENTYL]CARBAMATE;Carbamic acid, N-[(1S,2S)-1-formyl-2-methylbutyl]-, 1,1-dimethylethyl ester;tert-butyl N-[(1S,2S)-1-formyl-2-methyl-butyl]carbamate
• CAS NO: 87694-55-1
• Molecular Formula: C₁₁H₂₁NO₃
• Molecular Weight: 215.29
• Mol File: 87694-55-1.mol
• Article Data: 39

Chemical Properties

• Appearance: /
• CAS DataBase Reference: TERT-BUTYL [(1S,3S)-1-FORMYL-3-METHYLPENTYL]CARBAMATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL [(1S,3S)-1-FORMYL-3-METHYLPENTYL]CARBAMATE(87694-55-1)
• EPA Substance Registry System: TERT-BUTYL [(1S,3S)-1-FORMYL-3-METHYLPENTYL]CARBAMATE(87694-55-1)

Safety Data

• Hazardous Substances Data: 87694-55-1(Hazardous Substances Data)

Usage

General Description

TERT-BUTYL [(1S,3S)-1-FORMYL-3-METHYLPENTYL]CARBAMATE is a chemical compound with the molecular formula C14H27NO3. It is a carbamate derivative that consists of a tert-butyl group, a formyl group, and a methylpentyl group linked to a carbamate functional group. TERT-BUTYL [(1S,3S)-1-FORMYL-3-METHYLPENTYL]CARBAMATE is commonly used as a reagent in organic synthesis, particularly in the preparation of pharmaceuticals and agrochemicals. The presence of the formyl group makes it a versatile building block in the creation of various complex molecules. TERT-BUTYL [(1S,3S)-1-FORMYL-3-METHYLPENTYL]CARBAMATE is typically colorless and odorless, making it easy to handle in laboratory settings.

Upstream product

• 141321-52-0 N-(tert-butoxycarbonyl)-L-isoleucinol 
• 87694-51-7 N-(tert-butoxycarbonyl)-L-isoleucine N'-methoxy-N'-methylamide 
• 145929-76-6 N-(tert-butoxycarbonyl)-L-isoleucine N-carboxyanhydride 
• 17901-01-8 N-(tert-butoxycarbonyl)isoleucine methyl ester 
• 13139-16-7 N-(tert-butyloxycarbonyl)-L-isoleucine 
• 73-32-5 L-isoleucine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 118517-05-8 C₁₅H₂₇NO₆ 
• 13139-16-7 N-(t-butoxycarbonyl)-isoleucine 
• 545433-88-3 (S)-N-(tert-butoxycarbonyl)-isoleucinol 
• 214836-49-4 (2S,3S)-2-[N-(tert-butoxycarbonyl)amino]-1-imidazol-1-yl-3-methylpentan-1-one 
• 1296839-09-2 Boc-Ile-SEt 
• 106946-74-1 Boc-D-allo-isoleucinol 
• 1509-35-9 D-alloisoleucine 

Downstream Products

• 138802-21-8 [(2R,3R)-1-((S)-sec-Butyl)-2-hydroxy-3-methyl-4-((4R,5S)-4-methyl-2-oxo-5-phenyl-oxazolidin-3-yl)-4-oxo-butyl]-carbamic acid tert-butyl ester 
• 150350-31-5 (S)-2-((2S,3S)-2-tert-Butoxycarbonylamino-3-methyl-pentylamino)-3-phenyl-propionic acid methyl ester 
• 156924-92-4 (3S,4S)-(E)-(3-tert-butoxycarbonylamino)-4-methyl-1-phenyl-1-hexene 
• 405115-75-5 (S)-2-[(1S,2S)-2-Methyl-1-((E)-styryl)-butylcarbamoyl]-piperidine-1-carboxylic acid tert-butyl ester 
• 1026557-02-7 [Benzyl-((2S,3S)-2-tert-butoxycarbonylamino-3-methyl-pentyl)-amino]-acetic acid methyl ester 
• 160186-99-2 (S)-2-[((2S,3S)-2-tert-Butoxycarbonylamino-3-methyl-pentyl)-methyl-amino]-3-phenyl-propionic acid 
• 160187-09-7 (S)-2-[((2S,3S)-2-tert-Butoxycarbonylamino-3-methyl-pentyl)-methyl-amino]-3-phenyl-propionic acid methyl ester 
• 1027413-98-4 (S)-2-[Benzyl-((2S,3S)-2-tert-butoxycarbonylamino-3-methyl-pentyl)-amino]-3-phenyl-propionic acid methyl ester 
• 178270-38-7 N-[2(S)-(1,1-Dimethylethoxycarbonylamino)-3(S)-methylpentyl]-N-benzylglycyl-methionine methyl ester 
• 158861-40-6 (S)-2-[(S)-2-((2S,3S)-2-tert-Butoxycarbonylamino-3-methyl-pentylamino)-3-phenyl-propionylamino]-4-methylsulfanyl-butyric acid methyl ester 

Relevant articles and documents

Elastase Inhibitor Cyclotheonellazole A: Total Synthesis and in Vivo Biological Evaluation for Acute Lung Injury

Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is one of the most common complications in COVID-19. Elastase has been recognized as an important target to prevent ALI/ARDS in the patient of COVID-19. Cyclotheonellazole A (CTL-A) is a nat

Small molecule peptidomimetic trypsin inhibitors: validation of an EKO binding mode, but with a twist

Examination of a series of naturally-occurring trypsin inhibitor proteins, led to identification of a set of three residues (which we call the “interface triplet”) to be determinant of trypsin binding affinity, hence excellent templates for small molecule mimicry. Consequently, we attempted to use the Exploring Key Orientation (EKO) strategy developed in our lab to evaluate small molecules that mimic the interface triplet regions of natural trypsin inhibitors, and hence potentially might bind and inhibit the catalytic activity of trypsin. A bis-triazole scaffold (“TT-mer”) was the most promising of the molecules evaluated in silico. Twelve such compounds were synthesized and assayed against trypsin, among which the best showed a Kd of 2.1 μM. X-ray crystallography revealed a high degree of matching between an illustrative TT-mer's actual binding mode and that of the mimics that overlaid the interface triplet in the crystal structure. Deviation of the third side chain from the PPI structure seems to be due to alleviation of an unfavorable dipole-dipole interaction in the small molecule's actual bound conformation.

Synthesis, SAR and biological studies of sugar amino acid-based almiramide analogues: N-methylation leads the way

Leishmaniasis, caused by the protozoan parasites of the genus Leishmania, is one of the most neglected diseases endemic in many continents posing enormous global health threats and therefore the discovery of new antileishmanial compounds is of utmost urgency. The antileishmanial activities of a library of sugar amino acid-based linear lipopeptide analogues were examined with the aim to identify potential drug candidates to treat visceral leishmaniasis. It was found that among the synthesized analogues, most of the permethylated compounds exhibited more activity in in vitro studies against intra-macrophagic amastigotes than the non-methylated analogues. SAR and NMR studies revealed that introduction of the N-methyl groups inhibited the formation of any turn structure in these molecules, which led to their improved activities.